PRESS RELEASE published on 06/16/2025 at 09:20, 1 year ago Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 10th interim report Alzchem Group AG acquires 692 shares as part of a share buyback program. Detailed report available on company's website Share Buyback Stock Exchange Interim Report EU Regulation Alzchem Group AG
BRIEF published on 05/23/2025 at 09:05, 1 year ago Alzchem Group AG finalise sa planification de succession avec la nomination d'un nouveau directeur de l'exploitation Planification De La Relève Chef De L'exploitation Groupe Alzchem AG Produits Chimiques De Spécialité Dr Jürgen Sans
BRIEF published on 05/23/2025 at 09:05, 1 year ago Alzchem Group AG Finalizes Succession Planning with New COO Appointment Chief Operating Officer Succession Planning Alzchem Group AG Specialty Chemicals Dr. Jürgen Sans
PRESS RELEASE published on 05/23/2025 at 09:00, 1 year ago Alzchem Group AG successfully completes long-term succession planning for its Management Board: Supervisory Board appoints Dr. Jürgen Sans as Chief Operating Officer with effect from 1 January 2026 Alzchem Group AG successfully completes long-term succession planning as Supervisory Board appoints Dr. Jürgen Sans as Chief Operating Officer from January 1, 2026 Chief Operating Officer Supervisory Board Succession Planning Alzchem Group AG Dr. Jürgen Sans
BRIEF published on 05/09/2025 at 14:25, 1 year 1 month ago Alzchem Group AG augmente son dividende de 50 % et réélit son conseil de surveillance Exercice 2024 Conseil De Surveillance Valeur Actionnariale Assemblée Générale Annuelle Augmentation Des Dividendes
BRIEF published on 05/09/2025 at 14:25, 1 year 1 month ago Alzchem Group AG Increases Dividend by 50% and Re-elects Supervisory Board Annual General Meeting Shareholder Value Supervisory Board Fiscal Year 2024 Dividend Increase
PRESS RELEASE published on 05/09/2025 at 14:20, 1 year 1 month ago Alzchem Group AG: Annual General Meeting approves 50% dividend increase to EUR 1.80 and re-election of Supervisory Board members Alzchem Group AG approves 50% dividend increase to EUR 1.80 at Annual General Meeting and re-elects Supervisory Board members. Successful fiscal year 2024 showcased Annual General Meeting Supervisory Board Fiscal Year 2024 Dividend Increase Alzchem Group AG
BRIEF published on 04/30/2025 at 07:05, 1 year 1 month ago Alzchem Group AG Reports Continued Earnings Growth in Q1 2025 Alzchem Group AG EBITDA Growth Specialty Chemicals Q1 2025 Earnings Nitroguanidine Expansion
BRIEF published on 04/30/2025 at 07:05, 1 year 1 month ago Alzchem Group AG annonce une croissance continue de ses bénéfices au premier trimestre 2025 Croissance De L'EBITDA Groupe Alzchem AG Produits Chimiques De Spécialité Résultats Du Premier Trimestre 2025 Expansion De La Nitroguanidine
PRESS RELEASE published on 04/30/2025 at 07:00, 1 year 1 month ago Alzchem Group AG continues earnings growth in the first quarter of 2025; projects to expand nitroguanidine capacity launched Alzchem Group AG achieves earnings growth in Q1 2025 despite lower revenue, plans to expand nitroguanidine capacity. Positive outlook for sales and EBITDA growth in 2025 Earnings Growth Sales Forecast Alzchem Group AG Q1 2025 Nitroguanidine Expansion
Published on 06/22/2026 at 21:05, 1 hour 50 minutes ago RUM Announces Voting Results From Annual General Meeting of Shareholders
Published on 06/22/2026 at 19:45, 3 hours 10 minutes ago Trans Canada Gold Appoints Paradigm Drilling Ltd. for Drilling at the Harrison Lake District Scale Gold Project, Drilling to Commence Shortly
Published on 06/22/2026 at 15:58, 6 hours 57 minutes ago Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 15:30, 7 hours 25 minutes ago NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Published on 06/22/2026 at 15:00, 7 hours 55 minutes ago Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Published on 06/22/2026 at 21:07, 1 hour 48 minutes ago EQS-Adhoc: RWE Aktiengesellschaft: RWE sets placement price for shares from capital measure and raises gross proceeds of 4 billion EUR
Published on 06/22/2026 at 20:50, 2 hours 5 minutes ago Ethlabs, Founded by Former Ethereum Foundation Contributors and Funded by Bitmine, Sharplink and Joe Lubin, Launches to Accelerate Ethereum's Institutional Supercycle
Published on 06/22/2026 at 20:32, 2 hours 22 minutes ago EQS-Adhoc: Deutsche Konsum Real Estate AG: Daniel Löhken appointed Chief Executive Officer of the Company and Dr Kai Gregor Klinger appointed new Chairman of the Supervisory Board
Published on 06/22/2026 at 19:27, 3 hours 28 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 06/22/2026 at 18:54, 4 hours ago EQS-Adhoc: Brenntag SE publishes preliminary operating EBITDA for the second quarter of 2026 and increases its guidance for the financial year 2026
Published on 06/22/2026 at 18:00, 4 hours 55 minutes ago GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION